malondialdehyde has been researched along with cupric chloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, TW; Jacobi, H; Krieger, G; Vöhringer, ML; Witte, I | 1 |
| Azodi, M; Dunphy, G; Ely, DL; Richter, HW; Sellke, FW | 1 |
| Arnebrant, T; Fredrikson, GN; Jansson, B; Schiopu, A; Stollenwerk, MM; Svensson, O | 1 |
3 other study(ies) available for malondialdehyde and cupric chloride
| Article | Year |
|---|---|
Synergistic DNA damaging effects of malondialdehyde/Cu(II) in PM2 DNA and in human fibroblasts.
Topics: Administration, Topical; Anti-Inflammatory Agents; Bacteriophages; Cell Survival; Cells, Cultured; Chelating Agents; Copper; Dimethyl Sulfoxide; DNA Damage; DNA, Single-Stranded; DNA, Viral; Drug Synergism; Fibroblasts; Humans; Malondialdehyde; Phenanthrolines | 1998 |
Twenty-four-hour heart preservation using continuous cold perfusion and copper (II) complexes.
Topics: Animals; Antioxidants; Aspirin; Cold Temperature; Copper; Creatine Kinase; Heart; In Vitro Techniques; Lipid Peroxidation; Malondialdehyde; Myocardial Reperfusion Injury; Organ Preservation; Perfusion; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Solutions; Superoxide Dismutase; Time Factors; Ventricular Function, Left | 1998 |
Adsorption of low-density lipoprotein, its oxidation, and subsequent binding of specific recombinant antibodies: An in situ ellipsometric study.
Topics: Adsorption; Antibodies; Apolipoprotein B-100; Copper; Epitopes; Humans; Immunoglobulin G; Lipoproteins, LDL; Malondialdehyde; Oxidation-Reduction; Protein Binding; Recombinant Proteins; Refractometry; Silicon Dioxide; Surface Properties | 2011 |